Your browser doesn't support javascript.
loading
Effect of growth hormone treatment on diastolic function in patients who have developed growth hormone deficiency after definitive treatment of acromegaly.
Fazeli, Pouneh K; Teoh, Jonathan G; Lam, Eleanor L; Gerweck, Anu V; Wexler, Tamara L; Teo, Eliza P; Russell, Brian M; Durst, Ronen; McCarty, David; Weiner, Rory B; Picard, Michael H; Klibanski, Anne; Miller, Karen K.
Afiliación
  • Fazeli PK; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States. Electronic address: pkfazeli@partners.org.
  • Teoh JG; Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Lam EL; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Gerweck AV; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, United States.
  • Wexler TL; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Teo EP; Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Russell BM; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, United States.
  • Durst R; Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • McCarty D; Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Weiner RB; Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Picard MH; Division of Cardiology, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Klibanski A; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
  • Miller KK; Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA 02114, United States; Harvard Medical School, Boston, MA 02115, United States.
Growth Horm IGF Res ; 26: 17-23, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26774401
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acromegalia / Hormona de Crecimiento Humana / Terapia de Reemplazo de Hormonas / Diástole / Hipopituitarismo Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Growth Horm IGF Res Asunto de la revista: ENDOCRINOLOGIA Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acromegalia / Hormona de Crecimiento Humana / Terapia de Reemplazo de Hormonas / Diástole / Hipopituitarismo Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Growth Horm IGF Res Asunto de la revista: ENDOCRINOLOGIA Año: 2016 Tipo del documento: Article Pais de publicación: Reino Unido